Open original FDA record ↗Recall record
- FDA identifier
- Z-2220-2023
- Company in FDA record
- Datascope Corp.
- FDA classification date
- Jul 21, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
During IAB catheter insertion, the introducer dilator may fracture at the hub, leaving the body of the introducer dilator housed within the sheath. Risks to health include damage to the femoral artery, descending aorta, or embolization; surgical intervention and delay of IAB therapy may also result. Firm has received 10 complaints, including 3 serious adverse events and 1 patient death.
Source facts
- Action
- Firm notified customers on June 23, 2023 via letter. Customers were made aware of the potential for the device to break during use and the risk of using the device. Customers were given alternate solutions to continue using the IAB Catheter with alternative sheath/dilator combinations. Customers may also return their affected product for a credit. The firm will continue to ship product to customers who choose to continue receiving it. However, product currently being shipped is potentially affected by the same issue. Datascope/Getinge has identified the issue with the introducer dilator and is working with the supplier towards a resolution. If you have any questions, please contact your Datascope/Getinge representative or call Datascope/Getinge Customer Service at 1-888-943-8872, options 2, Monday through Friday, between the hours of 8:00 a.m. and 6:00 p.m. (Eastern Time Zone).
- Initiated
- 2023-06-23
- Root cause
- Under Investigation by firm
- Distribution
- Domestic distribution nationwide. International distribution worldwide.
- Recall number
- Z-2220-2023
- Recall status
- Open, Classified
- CDRH record ID
- 201301
- FDA classified
- 2023-07-21
- Recall event number
- 92527